gilteritinib
astellas
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'gilteritinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
had a great discussion with mark levis, md, phd, of , on the morpho trial of gilteritinib as post-transplant maintenance in flt3-itd aml #eha2023 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.